Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-10-14 4:05 pm Unchanged | 2025-10-07 | 13G | Salarius Pharmaceuticals, Inc. SLRX | C/M Capital Master Fund, LP | 0 0.000% | 0 (Unchanged) | Filing History |
| 2024-11-14 4:38 pm Purchase | 2024-09-30 | 13G | Salarius Pharmaceuticals, Inc. SLRX | Armistice Capital, LLC | 5,046 4.990% | 5,046 (New Position) | Filing History |
| 2024-02-14 3:54 pm Purchase | 2023-12-31 | 13G | Salarius Pharmaceuticals, Inc. SLRX | Armistice Capital, LLC | 3,561 9.990% | 3,561 (New Position) | Filing History |
| 2023-10-27 3:57 pm Purchase | 2023-10-23 | 13D | Salarius Pharmaceuticals, Inc. SLRX | Lee Elvin Sanghwan | 1,702 6.090% | 1,702 (New Position) | Filing History |
| 2023-02-13 4:30 pm Purchase | 2022-12-31 | 13G | Salarius Pharmaceuticals, Inc. SLRX | Lind Global Fund II LP | 742 3.800% | 742 (New Position) | Filing History |
| 2022-04-29 4:31 pm Purchase | 2022-04-26 | 13G | Salarius Pharmaceuticals, Inc. SLRX | Lind Global Fund II LP | 990 5.300% | 990 (New Position) | Filing History |
| 2022-04-27 10:52 am Purchase | 2022-04-22 | 13G | Salarius Pharmaceuticals, Inc. SLRX | Lincoln Park Capital Fund LLC | 990 5.980% | 990 (New Position) | Filing History |
| 2022-02-10 4:05 pm Sale | 2021-12-31 | 13G | Salarius Pharmaceuticals, Inc. SLRX | Sio Capital Management, LLC | 451 3.000% | -101 (-18.28%) | Filing History |
| 2021-02-16 1:03 pm Purchase | 2020-12-31 | 13G | Salarius Pharmaceuticals, Inc. SLRX | Sio Capital Management, LLC | 552 8.350% | 552 (New Position) | Filing History |
| 2021-02-16 10:07 am Unchanged | 2020-12-31 | 13G | Salarius Pharmaceuticals, Inc. SLRX | CVI Investments, Inc. | 268 4.100% | 0 (Unchanged) | Filing History |
| 2021-02-11 7:15 pm Sale | 2021-01-04 | 13G | Salarius Pharmaceuticals, Inc. SLRX | Orin Hirschman | 389 4.990% | -17 (-4.17%) | Filing History |
| 2021-01-28 2:25 pm Sale | 2020-12-31 | 13G | Salarius Pharmaceuticals, Inc. SLRX | Empery Asset Management, LP | 268 3.900% | -149 (-35.65%) | Filing History |